You can find more information about PF3D7_1114700-Protein kinase using the following links:

Subcellular Localization

• Picture 1
• Picture 2

Affecting Drugs
Drug Name	PubMed Articles (year of publication)
4-(2-{2-Methoxy-5-[(morpholin-4-yl)methyl]phenyl}-1H-pyrrolo[2,3-b]pyridin-4-yl)-2-(propan-2-yl)benzoic Acid	Development of Potent Pf CLK3 Inhibitors Based on TCMDC-135051 as a New Class of Antimalarials(2020)
Altiratinib	Altiratinib blocks Toxoplasma gondii and Plasmodium falciparum development by selectively targeting a spliceosome kinase(2022)
Aminopyrimidines	Inhibition of the SR protein-phosphorylating CLK kinases of Plasmodium falciparum impairs blood stage replication and malaria transmission(2014)
Oxo-b-carbolines	Inhibition of the SR protein-phosphorylating CLK kinases of Plasmodium falciparum impairs blood stage replication and malaria transmission(2014)
TCMDC-135051	Validation of the protein kinase Pf CLK3 as a multistage cross-species malarial drug target(2019)